Patrick McLeroth
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 3
- Clostridium difficile and Clostridium perfringens research 2
-
- Urinary Tract Infections Management 3
- Co-authors
- Alison Pedley (3 shared papers)Nicholas A. Kartsonis (3 shared papers)Amanda Paschke (3 shared papers)Michelle Brown (2 shared papers)Yu‐Chieh Lee (1 shared paper)Jiejun Du (1 shared paper)Matthew Sims (1 shared paper)Donatas Venskutonis (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)Open Forum Infectious Diseases (2 papers)Clinical Infectious Diseases (1 paper)The Lancet Infectious Diseases (1 paper)Nuclear Medicine and Biology (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Patrick McLeroth
13 papers receiving 602 citations
Patrick McLeroth's Hit Papers
Peers
Comparison fields: 5 of 61
- Molecular Medicine 300
- Applied Microbiology and Biotechnology 109
- Pharmacology 191
- Critical Care and Intensive Care Medicine 42
- Clinical Biochemistry 63
Countries citing papers authored by Patrick McLeroth
This map shows the geographic impact of Patrick McLeroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick McLeroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick McLeroth more than expected).
Fields of papers citing papers by Patrick McLeroth
This network shows the impact of papers produced by Patrick McLeroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick McLeroth. The network helps show where Patrick McLeroth may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick McLeroth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 156 | |
| 2 | 2017 | 135 | |
| 3 | 2019 | 93 | |
| 4 | Cefepime–Taniborbactam in Complicated Urinary Tract Infection Hit paper breakdown → | 2024 | 78 |
| 5 | 2016 | 45 | |
| 6 | 2017 | 44 | |
| 7 | 2018 | 34 | |
| 8 | 2022 | 11 | |
| 9 | 2019 | 8 | |
| 10 | 2017 | 8 | |
| 11 | 2002 | 6 | |
| 12 | 2002 | 1 | |
| 13 | A Phase 2 Study to Evaluate the Efficacy & Safety of Relebactam (REL) + Imipenem/Cilastatin (IMI) vs IMI Alone in Subjects with Complicated Intra-Abdominal Infection (cIAI) | 2015 | 1 |
About Patrick McLeroth
Patrick McLeroth is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 620 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (3 papers), Urinary Tract Infections Management (3 papers), Respiratory Support and Mechanisms (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Neonatal Respiratory Health Research (2 papers) and Toxoplasma gondii Research Studies (1 paper). The work is most often cited by research in Molecular Medicine (300 citations), Applied Microbiology and Biotechnology (109 citations), Pharmacology (191 citations), Critical Care and Intensive Care Medicine (42 citations) and Clinical Biochemistry (63 citations). Patrick McLeroth has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Alison Pedley, Nicholas A. Kartsonis, Amanda Paschke, Michelle Brown, Yu‐Chieh Lee, Jiejun Du, Matthew Sims, Donatas Venskutonis, Dorel Săndesc and Maria C Losada. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Clinical Infectious Diseases, The Lancet Infectious Diseases and Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.